BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 30597769)

  • 1. Langerhans cell histiocytosis in adults is associated with a high prevalence of hematologic and solid malignancies.
    Ma J; Laird JH; Chau KW; Chelius MR; Lok BH; Yahalom J
    Cancer Med; 2019 Jan; 8(1):58-66. PubMed ID: 30597769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term outcomes among adults with Langerhans cell histiocytosis.
    Goyal G; Acosta-Medina AA; Abeykoon JP; Dai C; Ravindran A; Vassallo R; Ryu JH; Shah MV; Bennani NN; Young JR; Bach CR; Ruan GJ; Zanwar S; Tobin WO; Koster MJ; Davidge-Pitts CJ; Gruber LM; Dasari S; Rech KL; Go RS
    Blood Adv; 2023 Nov; 7(21):6568-6578. PubMed ID: 37698994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Langerhans cell histiocytosis and associated malignancies: A retrospective analysis of 270 patients.
    Bagnasco F; Zimmermann SY; Egeler RM; Nanduri VR; Cammarata B; Donadieu J; Lehrnbecher T; Haupt R
    Eur J Cancer; 2022 Sep; 172():138-145. PubMed ID: 35772351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Langerhans cell histiocytosis first presenting in the skin in adults: frequent association with a second haematological malignancy.
    Edelbroek JR; Vermeer MH; Jansen PM; Stoof TJ; van der Linden MM; Horváth B; van Baarlen J; Willemze R
    Br J Dermatol; 2012 Dec; 167(6):1287-94. PubMed ID: 22835048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence, prevalence and survival in patients with Langerhans cell histiocytosis: A national registry study from England, 2013-2019.
    Liu H; Stiller CA; Crooks CJ; Rous B; Bythell M; Broggio J; Rankin J; Nanduri V; Lanyon P; Card TR; Ban L; Elliss-Brookes L; Broughan JM; Paley L; Wong K; Bacon A; Bishton M; West J
    Br J Haematol; 2022 Dec; 199(5):728-738. PubMed ID: 36122574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute leukemia in association with Langerhans cell histiocytosis.
    Egeler RM; Neglia JP; Aricò M; Favara BE; Heitger A; Nesbit ME
    Med Pediatr Oncol; 1994; 23(2):81-5. PubMed ID: 8202046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Langerhans cell histiocytosis of the temporal bone: A review of 29 cases at a single center.
    Modest MC; Garcia JJ; Arndt CS; Carlson ML
    Laryngoscope; 2016 Aug; 126(8):1899-904. PubMed ID: 26535795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late outcomes in children with Langerhans cell histiocytosis.
    Chow TW; Leung WK; Cheng FWT; Kumta SM; Chu WCW; Lee V; Shing MMK; Li CK
    Arch Dis Child; 2017 Sep; 102(9):830-835. PubMed ID: 28442470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Descriptive epidemiology of childhood Langerhans cell histiocytosis in France, 2000-2004.
    Guyot-Goubin A; Donadieu J; Barkaoui M; Bellec S; Thomas C; Clavel J
    Pediatr Blood Cancer; 2008 Jul; 51(1):71-5. PubMed ID: 18260117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of Langerhans cell histiocytosis in children: a population-based study.
    Stålemark H; Laurencikas E; Karis J; Gavhed D; Fadeel B; Henter JI
    Pediatr Blood Cancer; 2008 Jul; 51(1):76-81. PubMed ID: 18266220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vinblastine chemotherapy in adult patients with langerhans cell histiocytosis: a multicenter retrospective study.
    Tazi A; Lorillon G; Haroche J; Neel A; Dominique S; Aouba A; Bouaziz JD; de Margerie-Melon C; Bugnet E; Cottin V; Comont T; Lavigne C; Kahn JE; Donadieu J; Chevret S
    Orphanet J Rare Dis; 2017 May; 12(1):95. PubMed ID: 28532436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spectrum of second primary malignancies and cause-specific mortality in pediatric and adult langerhans cell histiocytosis.
    Goyal G; Parikh R; Richman J; Abeykoon JP; Morlote D; Go RS; Bhatia S
    Leuk Res; 2023 Mar; 126():107032. PubMed ID: 36758375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relation of Langerhans cell histiocytosis to acute leukemia, lymphomas, and other solid tumors. The LCH-Malignancy Study Group of the Histiocyte Society.
    Egeler RM; Neglia JP; Aricò M; Favara BE; Heitger A; Nesbit ME; Nicholson HS
    Hematol Oncol Clin North Am; 1998 Apr; 12(2):369-78. PubMed ID: 9561906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The annual incidence of Langerhans cell histiocytosis among adults living in Greece.
    Makras P; Stathi D; Yavropoulou M; Tsoli M; Kaltsas G
    Pediatr Blood Cancer; 2020 Sep; 67(9):e28422. PubMed ID: 32618036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Langerhans cell histiocytosis of skull: a retrospective study of 18 cases.
    Zhang XH; Zhang J; Chen ZH; Sai K; Chen YS; Wang J; Ke C; Guo CC; Chen ZP; Mou YG
    Ann Palliat Med; 2017 Apr; 6(2):159-164. PubMed ID: 28061539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Permanent consequences in Langerhans cell histiocytosis patients: a pilot study from the Histiocyte Society-Late Effects Study Group.
    Haupt R; Nanduri V; Calevo MG; Bernstrand C; Braier JL; Broadbent V; Rey G; McClain KL; Janka-Schaub G; Egeler RM
    Pediatr Blood Cancer; 2004 May; 42(5):438-44. PubMed ID: 15049016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The international dataset on the association between Langerhans Cell Histiocytosis and other malignancies.
    Bagnasco F; Zimmermann SY; Egeler RM; Nanduri VR; Cammarata B; Donadieu J; Lehrnbecher T; Haupt R
    Data Brief; 2022 Dec; 45():108604. PubMed ID: 36188132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and risk factors for clinical neurodegenerative Langerhans cell histiocytosis: a longitudinal cohort study.
    Héritier S; Barkaoui MA; Miron J; Thomas C; Moshous D; Lambilliotte A; Mazingue F; Kebaili K; Jeziorski E; Plat G; Aladjidi N; Pacquement H; Galambrun C; Brugières L; Leverger G; Mansuy L; Paillard C; Deville A; Pagnier A; Lutun A; Gillibert-Yvert M; Stephan JL; Cohen-Aubart F; Haroche J; Pellier I; Millot F; Gandemer V; Martin-Duverneuil N; Taly V; Hélias-Rodzewicz Z; Emile JF; Hoang-Xuan K; Idbaih A; Donadieu J
    Br J Haematol; 2018 Nov; 183(4):608-617. PubMed ID: 30421536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Langerhans Cell Histiocytosis Associated With Underlying Hematolymphoid Disorders in Adults: Report of 2 Cases and Review of the Literature.
    Kiavash K; Malone JC
    Am J Dermatopathol; 2018 Aug; 40(8):588-593. PubMed ID: 30035752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Langerhans cell histiocytosis of the head and neck in the pediatric population in a tertiary center: Clinical presentation, classification and treatment.
    García Díaz MP; De Luca Sologaistoa A; De Paula Vernetta C; Moreno MA; Galeano Paniagua LA; Fernández MM; Carceller MA
    Int J Pediatr Otorhinolaryngol; 2022 Apr; 155():111073. PubMed ID: 35220158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.